Phreesia SEC Filings

Form 144 filed for Phreesia, Inc. (PHR) shows a proposed sale of 2,059 common shares through Fidelity Brokerage Services with an aggregate market value of $48,386.50 and an approximate sale date of 09/17/2025. The shares were acquired by restricted stock vesting on 09/11/2025 and were issued as compensation. The filing reports total outstanding shares of 59,914,473. The filer also disclosed sales by Alison C. Hoffman within the past three months: 1,245 shares on 07/17/2025 for $33,472.82 and 3,133 shares on 09/16/2025 for $72,950.03. The notice includes the standard attestation that the seller is unaware of undisclosed material adverse information.

Phreesia, Inc. (PHR) filing reports a proposed sale of 940 common shares through Fidelity Brokerage Services with an aggregate market value of $21,887.34 and approximately 59,914,473 shares outstanding. The securities were acquired on 09/11/2025 through restricted stock vesting and the stated nature of payment is compensation. The filer lists an approximate sale date of 09/16/2025 on the NYSE. The filing also discloses recent open-market sales by the same person totaling 2,391 shares for $65,139.96 across trades dated 07/07/2025–07/18/2025. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Phreesia, Inc. (PHR) filed a Form 144 reporting an intended sale of 1,762 common shares with an aggregate market value of $41,027.11, expected to occur on 09/16/2025 on the NYSE. The shares were acquired on 09/11/2025 through restricted stock vesting and were received as compensation.

The filer, identified as Amy Vanduyn, previously sold 640 shares on 07/17/2025 for $17,206.91 and 18,573 shares on 08/25/2025 for $564,055.11. The filing discloses there are 59,914,473 shares outstanding. The document includes the broker name and address (Fidelity Brokerage Services LLC) and a standard attestation that the seller is not aware of undisclosed material adverse information.

Form 144 filing for Phreesia, Inc. (PHR) shows a proposed sale of 3,133 common shares with an aggregate market value of $72,950.03. The shares were acquired on 09/11/2025 through restricted stock vesting and payment classified as compensation. The planned sale date is 09/16/2025 on the NYSE. The filer reported a prior sale within three months: 1,245 shares sold on 07/17/2025 for $33,472.82. The filing lists total outstanding shares as 59,914,473. Several standard identifying fields (issuer address, filer CIK/CCC, and named filer contact) are not provided in the visible content.

Phreesia, Inc. insider filing notifies a proposed sale of 6,328 common shares through Fidelity Brokerage Services on the NYSE with an aggregate market value of $147,343.68, and an approximate sale date of 09/16/2025. The shares were acquired on 09/11/2025 upon restricted stock vesting as compensation. The filer also reported three sales during the past three months totaling 103,164 shares for gross proceeds of $3,210,162.74 (sales on 07/17/2025, 08/27/2025 and 08/28/2025). The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Form 144 filed for Phreesia, Inc. (PHR) reports a proposed sale of 2,051 common shares through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $47,756.30 and an approximate sale date of 09/16/2025. The shares were acquired on 09/11/2025 as restricted stock that vested and were received as compensation. The filer certifies no undisclosed material adverse information. The filing also discloses recent open-market sales by insiders in the past three months, including large disposals by David Linetsky totaling 41,174 shares across June–August 2025 and smaller sales by Jessica Weiss.

Form 144 Notice for Phreesia, Inc. (PHR) shows a proposed sale of 114 common shares through Fidelity Brokerage Services on 09/16/2025 with an aggregate market value of $2,654.42. The shares were acquired by the seller on 09/11/2025 upon restricted stock vesting and the consideration is listed as compensation. The filing reports the issuer has 59,914,473 shares outstanding. The document also lists multiple insider sales during the prior three months, including notable transactions by David Linetsky: 23,729 shares for $676,195.48 on 06/27/2025 and 17,445 shares for $518,681.81 on 08/22/2025. Other smaller sales by Jessica Weiss and additional sales by Linetsky are recorded with dates and gross proceeds. The filer certifies there is no undisclosed material adverse information known to the seller.

Form 144 filed for Phreesia, Inc. (PHR) reports a proposed sale of 3,761 common shares by a holder that acquired them on 09/11/2025 through restricted stock vesting and states the sale will be executed through Fidelity on the NYSE around 09/16/2025. The filing also discloses three prior sales by the same seller within the past three months: 1,892 shares on 07/17/2025 (gross proceeds $50,867.93), 45,147 shares on 08/27/2025 (gross proceeds $1,445,601.82) and 3,400 shares on 08/28/2025 (gross proceeds $110,369.37). The filer certifies no undisclosed material adverse information.

Phreesia, Inc. (PHR) filing of Form 144 reports a proposed sale of 4,183 common shares to be sold through Fidelity Brokerage Services on 09/16/2025 with an aggregate market value of $97,398.65. The shares were acquired on 09/11/2025 via restricted stock vesting and were paid as compensation. The filer, identified in prior sales as Balaji Gandhi, sold 886 shares on 07/17/2025 for $23,820.82 and 9,583 shares on 08/25/2025 for $287,550.07. The notice includes the standard representation that the seller does not possess undisclosed material adverse information about the issuer.